Latest News

Teck Resources has already announced that it would release its fourth-quarter 2025 earnings on February 19, 2026, while also exiting a copper exploration alliance in Kazakhstan and increasing its ownership position in Intrepid Metals through a C$6.5 million private placement to support the Corral Copper Project. Together, walking away from the Kazakhstan option on underwhelming copper results and backing Intrepid’s Corral Copper Project points to a reorientation of Teck’s early-stage growth...

Live Oak Bancshares (NYSE:LOB) CEO James S. Mahan III recently sold company stock under a pre arranged trading plan. The sale followed the release of strong fourth quarter results that exceeded prior expectations. The timing and size of the insider sale are drawing attention from shareholders and market watchers. Live Oak Bancshares focuses on lending to small businesses, an area that can be closely tied to broader economic activity and credit conditions. After the company reported strong...

Round One (TSE:4680) has put out its Q3 2026 scorecard, reporting revenue of ¥43,680 million and basic EPS of ¥9.48. These figures help set the tone for how its latest quarter lands with investors who are watching both growth and margin trends. The company has seen quarterly revenue move between ¥40,606 million and ¥50,420 million over the past six reported periods, while basic EPS has ranged from ¥9.36 to ¥20.76. This gives a clear sense of how earnings power has swung through recent...

First Solar (FSLR) is back in focus after investors reacted to its extended contracted backlog through 2030, solid annual revenue growth, and a positive free cash flow margin, all set against rising U.S. electricity demand. See our latest analysis for First Solar. Despite a 43.57% 1-year total shareholder return, First Solar’s recent share price has cooled, with a 16.99% year to date share price decline and an 11.25% 3-month share price return reflecting some hesitation after strong backlog...

Tanabe Consulting GroupLtd (TSE:9644) has released its Q3 2026 scorecard, reporting revenue of ¥4.7b, net income of ¥365m and EPS of ¥11.26 for the quarter. The company’s revenue moved from ¥4.5b and EPS of ¥11.60 in Q3 2025 to ¥4.7b and EPS of ¥11.26 in Q3 2026, alongside 14.5% earnings growth over the last 12 months and a 6.7% net profit margin. For investors, that combination of a steady top line, trailing earnings expansion and slightly higher margins frames a results season focused on...

Blue Bird (BLBD) is back in focus after its latest quarterly update, as investors weigh higher sales, a sharp pickup in orders, firmer margins, and reaffirmed full year guidance against the stock’s recent strong performance. See our latest analysis for Blue Bird. The earnings update appears to have reinforced an already strong run, with a 7 day share price return of 16.26% and a year to date share price return of 23.55%, while the 1 year total shareholder return of 61.87% and 3 year total...

Bank of America (NYSE:BAC) is joining other major US banks in calling for limits on stablecoin interest payments and urging Congress to act as the Clarity Act stalls. The bank is sharing an upbeat view on the US economy, with its CEO pointing to real time consumer spending data. Merrill advisors at Bank of America are gaining broad recognition in Forbes' Top Women Wealth Advisors lists. For you as an investor, these updates touch on several key parts of Bank of America’s business model,...

Leadership change as a new lens on Rubrik stock Rubrik (RBRK) has put revenue execution in the spotlight after promoting Jesse Green to Chief Revenue Officer. This move could shape how investors think about the company’s go to market path. See our latest analysis for Rubrik. Rubrik’s share price is US$55.12 after a 6.27% 7 day share price return. However, a 26.96% year to date share price decline and a 28.92% 1 year total shareholder return decline suggest momentum has been fading despite...

Sanofi's ENXTPA:SAN rilzabrutinib received breakthrough therapy designation from the US FDA for warm autoimmune hemolytic anemia. The same drug received orphan drug designation from Japanese health authorities for this rare blood disorder. Sanofi reported progress in its rare disease pipeline, including late stage data for venglustat in neurological Gaucher disease and regulatory steps for Rezurock in Europe. The company is also expanding its use of AI in drug discovery and manufacturing to...

Sakai Moving ServiceLtd (TSE:9039) has posted its Q3 2026 results with revenue of ¥26.5 billion and basic EPS of ¥20.39. The company also reported trailing 12 month EPS of ¥208.28 on revenue of ¥123.5 billion that reflects a 7.7% earnings increase year over year. Over the past few quarters, the company has seen revenue range from ¥26.3 billion to ¥36.2 billion and quarterly EPS move between ¥19.99 and ¥85.79, while net profit margin has edged up to 6.8% from 6.6%. This may prompt investors to...

Optex Systems Holdings (OPXS) has just posted its latest Q1 2026 numbers, with recent quarterly revenue sitting at US$11.3 million, basic EPS at roughly US$0.15 and trailing 12 month earnings growth of 36.4% backed by a net profit margin of 12.5% versus 11.1% a year ago. Over the past few quarters, the company has seen revenue move from US$9.4 million in Q4 2024 to US$11.3 million in Q4 2025. Basic EPS across those same quarters ranged between about US$0.12 and US$0.26, reflecting how the...

Logistri Fastighets (DB:6DV0) has put fresh numbers on the table for FY 2025, reporting Q3 total revenue of SEK46.8 million alongside basic EPS of SEK0.48. Trailing 12-month figures show revenue of SEK168.6 million and EPS of SEK1.34, with earnings over the last year rising 11.1%. The company has reported an increase in revenue from SEK135.1 million to SEK168.6 million on a trailing 12-month basis, with EPS over that period moving from SEK0.88 to SEK1.34. Results were affected by a one-off...

Earlier this month, Lamar Advertising Company confirmed it had acquired Cleveland Outdoor Advertising’s assets for cash, adding 31 high-profile bulletin faces and 40 junior bulletin faces to its Cleveland portfolio. This targeted expansion in a single metro area highlights how Lamar is using bolt-on deals to deepen local density rather than pursuing large-scale national rollups. We’ll now explore how this Cleveland portfolio expansion affects Lamar’s investment narrative, particularly its...

Newmont (NYSE:NEM) is in a dispute with Barrick over the performance and management of their Nevada Gold Mines joint venture. Newmont is asserting its rights under the joint venture agreement, including the potential to block Barrick's proposed IPO of the Nevada Gold Mines asset. The disagreement centers on how this core mining asset is being run and what its future ownership and control should look like. For shareholders, this is not a side issue. Nevada Gold Mines is a key asset, and...

ULVAC (TSE:6728) has posted Q2 2026 results with revenue of ¥71,164 million and basic EPS of ¥92.24, backed by net income of ¥4,538 million, putting a solid set of hard numbers in front of investors. The company has seen quarterly revenue move from ¥73,853 million in Q2 2025 to ¥71,164 million in Q2 2026, while basic EPS shifted from ¥135.60 to ¥92.24 over the same period. This gives a clear view of how the top and bottom line are tracking year on year, with margins coming under pressure on a...

ANEST IWATA (TSE:6381) has released its Q3 2026 numbers, reporting revenue of ¥13.2b and basic EPS of ¥30.88. Trailing twelve month revenue stands at ¥53.9b and EPS at ¥103.54. Over recent quarters, the company’s revenue has moved from ¥14.6b in Q2 2025 to ¥14.4b in Q4 2025, then to ¥12.1b in Q1 2026, ¥14.2b in Q2 2026, and ¥13.2b in Q3 2026. Basic EPS ranged from ¥28.82 to ¥35.05 in 2025 and from ¥22.75 to ¥32.12 in the first half of 2026 before the latest figure. With trailing net margins...

Kappa Create (TSE:7421) has reported a mixed Q3 2026, with revenue of ¥17,964 million and a net loss of ¥378 million, translating into basic EPS of ¥7.66. Over recent quarters, the company has seen revenue move in a fairly tight band between ¥18,060 million and ¥19,139 million, while EPS has ranged from ¥4.82 to ¥8.25 before this latest quarterly loss. This sets up a contrast with trailing twelve month EPS of ¥13.70 and net income of ¥676 million on revenue of ¥73,196 million. For investors,...

NNN REIT (NNN) has put up another steady set of numbers, with Q3 FY 2025 revenue at US$230.2 million and basic EPS of US$0.51, while trailing twelve month revenue sits at US$906.3 million and basic EPS at US$2.09. The company has seen quarterly revenue move from US$216.8 million in Q2 FY 2024 to US$230.9 million in Q1 FY 2025 and US$226.8 million in Q2 FY 2025. Over the same period, quarterly EPS has ranged between roughly US$0.51 and US$0.58, which sets the stage for investors to focus on...

Kilroy Realty (KRC) has been drawing attention after a stretch of negative returns, with the stock down over the past week, month, and past 3 months. This has prompted investors to reassess its current valuation. See our latest analysis for Kilroy Realty. At a share price of US$32.22, Kilroy Realty has seen selling pressure build recently, with a 30-day share price return of 17.02% and a 90-day move of 22.64%. The 1-year total shareholder return of 2.40% and 5-year total shareholder return of...

ALS Limited recently completed a A$350,000,000 capital raising to expand laboratory capacity, support growth initiatives, and maintain balance sheet flexibility across its Commodities and Life Sciences operations. This funding bolsters ALS’s ability to invest in higher-demand testing areas and pursue acquisitions that could reshape its service mix and geographic reach. We’ll now examine how this fresh A$350,000,000 investment pool may influence ALS’s existing investment narrative and future...

In early February 2026, Mitsui Chemicals’ board approved a share repurchase of 18,400,000 shares for ¥30,000 million and governance changes, while the company also reported nine-month sales of ¥1.22 trillion and basic EPS of ¥120.14. A day later, Mitsui Chemicals joined thirteen partners across five countries in what Sony announced as the world’s first global supply chain for renewable plastics for high-performance audio-visual products, positioning the group to better track emissions and...

Revvity (NYSE:RVTY) introduced several new discovery platforms and technologies at SLAS2026. The launches span high content screening, plate reading, and laboratory automation tools. The new products are designed to support faster drug discovery and streamlined lab workflows. Revvity, trading at around $101.1, is adding fresh products to its life sciences tools portfolio at a time when its 1 year return sits at a decline of 8.9% and its 3 year and 5 year returns show declines of 24.7% and...

Iida Group Holdings (TSE:3291) has released its Q3 2026 numbers with revenue of ¥371.7b and basic EPS of ¥65.36, giving investors fresh data on how the current year is shaping up. The company’s revenue moved from ¥362.8b in Q3 2025 to ¥371.7b in Q3 2026, while basic EPS shifted from ¥51.30 to ¥65.36 over the same period, and trailing twelve month EPS now sits at ¥201.00 alongside net income of ¥55.6b. Taken together with a reported net margin of 3.8% over the last year versus 3.0% previously,...

DorianG (LPG) is back in focus after reporting third quarter results that showed higher revenue and net income year over year, alongside an irregular US$0.70 per share cash dividend to shareholders. See our latest analysis for DorianG. The strong third quarter update and irregular dividend appear to be feeding into already firm momentum, with a 15.49% 1 month share price return and a 54.24% 1 year total shareholder return. The 5 year total shareholder return of over 4x points to a powerful...